cepharanthine has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Q; Chen, P; Feng, Y; Li, Z; Liu, H; Su, G; Wang, X; Wang, Y; Xu, D; Zhang, R; Zhou, P | 1 |
| Nakano, H; Nakatani, K; Ohnishi, T; Sawada, H; Watanabe, A; Yamada, Y; Yano, T | 1 |
2 other study(ies) available for cepharanthine and Esophageal Neoplasms
| Article | Year |
|---|---|
Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bacteria; Benzylisoquinolines; Cell Line, Tumor; Cisplatin; Disease Models, Animal; DNA, Ribosomal; Drug Synergism; Drug Therapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gastrointestinal Microbiome; Humans; Immunity; Immunity, Innate; Intestinal Mucosa; Metagenomics; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Differentiation Factor 88; Signal Transduction; Toll-Like Receptor 4; Xenograft Model Antitumor Assays | 2019 |
Additive effects of cepharanthin in CDDP/hyperthermia combination therapy against transplantable human esophageal cancer in nude mice.
Topics: Alkaloids; Animals; Benzylisoquinolines; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Humans; Hyperthermia, Induced; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation | 1994 |